Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock, par value, $0.001 per share
-
Shares outstanding
-
50M
-
Number of holders
-
19
-
Total 13F shares, excl. options
-
2.62M
-
Shares change
-
+1.68M
-
Total reported value, excl. options
-
$2.33M
-
Value change
-
+$1.49M
-
Put/Call ratio
-
0.04
-
Number of buys
-
10
-
Number of sells
-
-3
-
Price
-
$0.89
Significant Holders of NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share (NMTC) as of Q3 2023
21 filings reported holding NMTC - NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share as of Q3 2023.
NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share (NMTC) has 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.62M shares
of 50M outstanding shares and own 5.23% of the company stock.
Largest 10 shareholders include Nantahala Capital Management, LLC (1.25M shares), VANGUARD GROUP INC (439K shares), Walleye Capital LLC (226K shares), Mayo Clinic (182K shares), GEODE CAPITAL MANAGEMENT, LLC (178K shares), PERKINS CAPITAL MANAGEMENT INC (150K shares), STATE STREET CORP (51.6K shares), SG Americas Securities, LLC (50.5K shares), MAI Capital Management (50K shares), and NORTHERN TRUST CORP (19.9K shares).
This table shows the top 19 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.